Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
September 19, 2017	CT ORDER	CT ORDER	9999999997-17-008760.pdf View HTML
October 2, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-003085.pdf 0001562180-17-003085.rtf 0001562180-17-003085.xls View HTML
October 4, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-003206.pdf 0001562180-17-003206.rtf 0001562180-17-003206.xls View HTML
October 4, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-003207.pdf 0001562180-17-003207.rtf 0001562180-17-003207.xls View HTML
October 4, 2017	4	Statement of changes in beneficial ownership of securities	0001562180-17-003205.pdf 0001562180-17-003205.rtf 0001562180-17-003205.xls View HTML
November 7, 2017	SC 13G/A	An amendment to the SC 13G filing	0001104659-17-066647.pdf 0001104659-17-066647.rtf 0001104659-17-066647.xls View HTML
November 8, 2017	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-17-022727.pdf 0001564590-17-022727.rtf 0001564590-17-022727.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
November 28, 2017	CT ORDER	CT ORDER	9999999997-17-010082.pdf View HTML
January 8, 2018	SC 13G/A	An amendment to the SC 13G filing	0000790502-18-000001.pdf 0000790502-18-000001.rtf View HTML
January 26, 2018	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-18-021657.pdf 0001193125-18-021657.rtf 0001193125-18-021657.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax